Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 3/20 | 0.47 |
| ▸ | CA1 | P00915 | 3/20 | 0.47 |
| ▸ | CA9 | Q16790 | 3/20 | 0.47 |
| ▸ | CA2 | P00918 | 1/20 | 0.47 |
| ▸ | ZDHHC20 | Q5W0Z9 | 2/20 | 0.46 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.46 |
| ▸ | MGLL | Q99685 | 1/20 | 0.42 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.41 |
| ▸ | MMP1 | P03956 | 1/20 | 0.41 |
| ▸ | MMP2 | P08253 | 1/20 | 0.41 |
| ▸ | MMP3 | P08254 | 1/20 | 0.41 |
| ▸ | MMP8 | P22894 | 1/20 | 0.41 |
| ▸ | CES2 | O00748 | 3/20 | 0.39 |
| ▸ | CES1 | P23141 | 3/20 | 0.39 |
| ▸ | KDM5A | P29375 | 3/20 | 0.39 |
| ▸ | PHF8 | Q9UPP1 | 3/20 | 0.39 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6161695 | 1.00 | CA12 (0.47) | CA12CA1CA9CA2ZDHHC20 | |
| SCHEMBL6165557 | 1.00 | CA12 (0.47) | CA12CA1CA9CA2ZDHHC20 | |
| SCHEMBL6162339 | 1.00 | CA12 (0.47) | CA12CA1CA9CA2ZDHHC20 | |
| SCHEMBL6164439 | 1.00 | CA12 (0.47) | CA12CA1CA9CA2ZDHHC20 | |
| SCHEMBL6163385 | 0.98 | CA12 (0.45) | CA12CA1CA9CA2ZDHHC20 | |
| SCHEMBL5209092 | 0.91 | CA1 (0.52) | CA12CA1CA9CA2ZDHHC20 | |
| SCHEMBL5206242 | 0.87 | SIGMAR1 (0.49) | CA12CA1CA9CA2ZDHHC20 | |
| SCHEMBL8860912 | 0.83 | CA12 (0.44) | CA12CA1CA9CA2ZDHHC20 | |
| SCHEMBL5206297 | 0.83 | CA12 (0.55) | CA12CA1CA9CA2MGLL | |
| SCHEMBL28705123 | 0.83 | NPC1 (0.53) | CA12CA1CA9CA2ZDHHC20 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7205083-B2 | Recording material | FUJIFILM CORPORATION (JP) | 2007-04-17 | — | — | US | disclosed |
| EP-1055712-B1 | Aqueous ink for ink jet recording | MITSUI CHEMICALS INC (JP) | 2005-02-16 | — | — | EP | disclosed |
| US-6825373-B2 | REACTING AN AMINOPYRROL DERIVATIVE WITH AND ISOTHIOCYANATOFORMIC ACID ESTER DERIVATIVE TO FORM AN ADDUCT,CYCLIZING THE ADDUCT TO FORM PYRROLOTRIAZIN-4-ONE DERIVATIVE | FUJI PHOTO FILM CO., LTD. (JP) | 2004-11-30 | — | — | US | disclosed |
| US-6787502-B2 | INCLUSION OF A STRONGLY BASIC BIS-GUANIDINE COMPOUND THAT IS SUPERIOR IN DIFFUSION RESISTANCE; SPECIFIED DIAZONIUM SALT COMPOUND AND A PYRROLO(1,2-A)PYRIMIDINE COUPLER IN RECORDING LAYER | FUJI PHOTO FILM CO., LTD. (JP) | 2004-09-07 | — | — | US | disclosed |
| US-20040082472-A1 | Recording material | FUJI PHOTO FILM CO., LTD. | 2004-04-29 | — | — | US | disclosed |
| US-20040048185-A1 | Heat-sensitive recording material | FUJI PHOTO FILM CO., LTD | 2004-03-11 | — | — | US | disclosed |
| US-20030158038-A1 | Guanidine compound and heat sensitive recording material | FUJI PHOTO FILM CO., LTD. | 2003-08-21 | — | — | US | disclosed |
| US-6600041-B2 | Cyclization of an aminopyrrole compound | FUJI PHOTO FILM CO., LTD. (JP) | 2003-07-29 | — | — | US | disclosed |
| US-20030077542-A1 | Photopolymerizable composition, recording material and image forming method | FUJI PHOTO FILM CO., LTD. | 2003-04-24 | — | — | US | disclosed |
| US-20020128479-A1 | Method of preparing pyrrolotriazin-4-one compound and method of preparing isothiocyanatoformic acid ester derivative that is a reactant used for preparing pyrrolotriazin-4-one compound | FUJI PHOTO FILM CO., LTD. | 2002-09-12 | — | — | US | disclosed |
| US-6147051-A | ANTIISCHEMIC AGENT | TAKEDA CHEMICAL INDUSTRIES LTD. (JP) | 2000-11-14 | — | — | US | disclosed |
| US-5925489-A | CONTAINING DIAZONIUM SALT AND PYRROLOPYRIMIDINE COUPLER WHICH REACT WHEN HEATED TO DEVELOP VIOLET TO CYAN COLORS, IMAGE QUALITY AND STABILITY, SHELF LIFE | FUJI PHOTO FILM CO., LTD. (JP) | 1999-07-20 | — | — | US | disclosed |
| EP-0499266-B1 | Endothelin antagonist | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 1996-07-10 | — | — | EP | disclosed |
| EP-0626174-A2 | Methods and compositions for the prophylactic and/or therapeutic treatment of organ hypofunction | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1994-11-30 | — | — | EP | disclosed |
| US-5352659-A | Polypeptide; hypotensive agents | TAKEDA CHEMICAL INDUSTRIES (JP) | 1994-10-04 | — | — | US | disclosed |
| US-5306808-A | Endothelin derivatives | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1994-04-26 | — | — | US | disclosed |
| EP-0547317-A1 | Endothelin antagonists | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1993-06-23 | — | — | EP | disclosed |
| EP-0499266-A1 | Endothelin antagonist | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1992-08-19 | — | — | EP | disclosed |
| EP-0470256-A1 | PEPTIDE DERIVATIVES AND PRODUCTION THEREOF | Takeda Chemical Industries, Ltd. (JP) | 1992-02-12 | — | — | EP | disclosed |
| WO-1991013089-A1 | PEPTIDE DERIVATIVES AND PRODUCTION THEREOF | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1991-09-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020128479-A1 | Method of preparing pyrrolotriazin-4-one compound and method of preparing isothiocyanatoformic acid ester derivative that is a reactant used for preparing pyrrolotriazin-4-one compound | PPOX, QPCT, DDT | CA12 3648/4885CA1 2272/4885CA9 2865/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.